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ABSTRACT
Background: ECMO constitutes a complex support modality, and accurate monitoring is required. 
An ideal monitoring system should promptly detect ECMO malfunctions and provide real-time 
information to optimize the patient-machine interactions. We tested a new volumetric capnometer 
which enables continuous monitoring of membrane lung carbon dioxide removal (V'CO2ML), to help 
in estimating the oxygenator performance, in terms of CO2 removal and oxygenator dead space 
(VDsML). 
Methods: The current study was conducted on 9 pigs undergoing veno-arterial ECMO due to 
cardiogenic shock after induced acute myocardial infarction. The accuracy and reliability of the 
prototype of the volumetric capnometer (CO2RESET™, by Eurosets srl, Medolla, Italy) device was 
evaluated for V'CO2ML and VDsML measurements by comparing the obtained measurements from 
the new device to the standard method with the use of a standard capnometer and the sweep gas 
values. Measurements were taken at five different levels of gas flow/blood flow ratio (0,5-1,5). The 
agreement between the corresponding measurements taken with the two methods was assessed. 
We expected that 95% of differences was between d-1.96s and d +1.96s.
Results: 120 coupled measurements from each device were obtained for the V'CO2ML calculation 
and 40 for the VDsML. The new capnometer mean percentage bias (95% CI of limits of agreement) 
was 3.86% (12.07 – 4.35%) for V'CO2ML, and 2.62% (8.96 – 14.20%) for VDsML. A negative 
proportional bias for V'CO2ML estimation with the new device was observed with a mean of 3.86% 
(12.07 – 4.35%). No correlations were found between differences in the coupled V'CO2ML and 
VDsML measurements and the gas flow/blood flow ratio or temperature. Coupled measurements for 
V'CO2ML showed a strong correlation (rs=0.991; p=0.0005), as did VDsML calculations (rs=0.973; 
p=0.0005).
Conclusion: The volumetric capnometer is reliable for continuous monitoring of CO2 removal by ML 
and VDsML calculations. Further studies are necessary to confirm these data.
Keywords: Capnometer, Membrane Lung Carbon Dioxide Removal, Extracorporeal Membrane 
Oxygenation monitoring, Oxygenator performance, Membrane Lung Function, V’CO2, ECMO, ECLS
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Background
In recent years, there has been a significant increase of extracorporeal membrane oxygenation 
(ECMO) utilization for both cardiac (VA-ECMO) and respiratory (VV-ECMO) support1. However, 
ECMO is a complex system that requires prompt changes in its settings on the basis of the rapid 
variations of the patients’ conditions. Accurate monitoring of vital body parameters is, therefore, a 
key factor for the early detection of complications and the proper management of the cardiac and 
respiratory support 2. Thus, an optimal monitoring equipment should provide information regarding 
the pump function as revolution per minute (rpm), blood flow (l/min), inlet and outlet pressures 
(mmHg) and the membrane lung performance 3. Evaluation of the membrane lung (ML) performance 
is of paramount importance during ECMO not only because it might indicate a gradual or sudden 
functional impairment and therefore the need and the timing for the membrane lung replacement 
due to clot formation inside the oxygenator, but may also provide information regarding both the 
native lung (NL) and the ML contribution to the global ventilation, hence guiding the weaning 
process4. 
Furthermore, as for the NL, the ML performance is assessed by measuring both the O2 transfer 
(V'O2ML) and CO2 removal (V'CO2ML) through the oxygenator.
Whilst some devices applied to the ECMO circuits already allow for continuous monitoring of 
V'O2ML, there are only two systems currently available for the continuous monitoring of V'CO2ML. 
However, the continuous evaluation of CO2 removal by ML (V'CO2ML) is extremely important since 
it also allows the ML dead space calculation (VDsML), which can be altered due to clot formation 
inside the oxygenator and fibres oedema (as the plasma leakage phenomenon). In this situation, 
fractions of the ML are ventilated but not perfused, hence they do not participate in the CO2 removal. 
Moreover, a continuous measurement of the CO2 removed by the oxygenator allows a more precise 
distinction between the different contributions of both the patient and the oxygenator to the global 
ventilation and, hence, provide significant information during weaning from the ECMO machine. 
Moreover, a continuous monitoring of CO2 percentage in the exhaust gas could be used as an alarm 
of gas flow failure or disconnection. 
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In our experimental study, we tested the accuracy and the reliability of a new volumetric capnometer 
which enables continuous monitoring of V'CO2ML by the direct measurement of the CO2 partial 
pressure at the exhaust gas port of the membrane lung (%) and the gas flow (l/min),The  and to 
calculate the dead space during ECMO.
 
Methods
The current animal model experiment was conducted at the University Hospital of Maastricht, The 
Netherland on nine pigs undergoing veno-arterial ECMO (VA ECMO). The protocol was approved 
by the ethical committee of the University Hospital of Maastricht (protocol number WP 2015-003-
001). 
The pigs were anaesthetized, intubated, ventilated by constant ventilator settings. The present study 
was conducted as part of a major one aimed at comparing the effects of treatments alone with VA 
ECMO in addition to IABP (intra-aortic balloon pump) in pigs in cardiogenic shock. Such a condition 
was obtained by inducing an acute myocardial infarction (left anterior descending coronary artery 
ligature), and, after four hours of monitoring, the two capnometers were tested.  The tubing set and 
the ECMO oxygenators (model “adult ECMO 14 days”) were provided by Eurosets srl, Medolla, Italy.
In more details, we evaluated the accuracy and reliability of a prototype of a new volumetric 
capnometer device (CO2RESET™, Eurosets srl, Medolla, Italy) that provide directly and continuolsy 
the V'CO2ML values and the VDsML calculation, by comparing the obtained measurements with the 
new device to the ones obtained with a standard method. 
The standard method used a normal capnometer (Microcap Plus®Capnograph, Medtronic, 
Minneapolis, Minnesota, USA) which was routinely used in clinics for measurments of the CO2 
concentration  in the exhaled air of the patient (the end-tidal CO2, expressed as %) and the values 
of gas flow displayed on the standard gas blender.
We measured V'CO2ML and VDsML at five different levels of gas flow/blood flow ratio (0,5-1,5) and 
we obtained three V'CO2ML measurements for each level of gas flow/blood flow ratio (in total, 135 
couples of values expected), while only one for the VDsML at each level of gas flow/blood flow (in 
total, 45 couples of values expected). We performed a blood gas analysis at each level of gas 
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flow/blood flow to obtain the inlet blood pCO2 and the outlet blood pCO2. Moreover, we also 
continuously recorded both pigs’ body and exhaust gas temperatures. 
Devices Characteristics:
The new device consists of a mid-mange infrared sensor placed mainstream (compared to the 
standard device with side-stream sampling) to the oxygenator exhaust connector, combined with  a 
flow sensor device placed at the oxygenator gas inlet (Figure 1). The CO2 concentration is calculated 
on the basis of the radiation variation caused by the CO2 absorption characteristics, as with the 
common capnometers. However, not only does the combination of the capnometer and the 
flowmeter allows the continuous evaluation of the percentage of CO2 exhaust by the ML, but also 
the continuous V'CO2ML calculation. Furthermore, a system placed inside the capnometer maintains 
the temperature of the gas exhaust between 40-42°C, avoiding condensation as well as misleading 
measurements. Ultimately, a dedicated software tool calculates the measurements and shows CO2 
[%], CO2 [mmHg], inlet gas flow [l/min] and V'CO2ML [ml/min].
The standard hand-held capnometer is a clinically validated device for measuring the CO2 
concentration in patient exhaled gases. It works with an internal sensor (based on radiation 
absorption technology) by sampling the gases from the exhaust gas port of the oxygenator through 
a narrow tube. It is possible to calculate intermittently the V'CO2ML combined the CO2 percentage 
obtained by the standard capnometer with the contemporary value of sweep gas set on the gas 
blender.
V'CO2ML and Dead Space Monitoring
While the CO2 concentration in the exhaust gas (%CO2) from the ML and V'CO2ML were directly 
shown on the screen by “CO2RESET™” capnometer’s software, the value of V'CO2ML derived from 
the measured %CO2 with the second method was calculated as follows
𝑉′𝐶𝑂2𝑀𝐿 [𝑚𝑙 𝑚𝑖𝑛] =  %𝐶𝑂2 𝑥 𝐺𝐹 [𝑙 𝑚𝑖𝑛]𝑥 10
where GF is the gas flow, %CO2 is the concentration as percentage of CO2 in exhaust gas, and  
V'CO2ML is the membrane lung carbon dioxide removal.
In addition, the two methods were compared for the dead space calculation, which was obtained by 
the following equation:
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𝑉𝐷𝑠𝑀𝐿 [%] = 100 (𝑝𝐶𝑂2 𝑜𝑢𝑡 [𝑚𝑚𝐻𝑔] ― %𝐶𝑂2 )𝑝𝐶𝑂2 𝑜𝑢𝑡 [𝑚𝑚𝐻𝑔]
where the VDsML is the membrane lung dead space, the pCO2out is the carbon dioxide partial 
pressure into the outlet blood, and the %CO2 is the concentration of carbon dioxide in the gas 
sampled at the exhaust gases port of the oxygenator.
Statistical Analysis:
Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 24, IBM 
Corporation 2015, Armonk, NY.
The correlations between all the obtained measurements with the new volumetric capnometer and 
the ones obtained with the standard method (Microcap Plus®Capnograph, Medtronic, Minneapolis, 
Minnesota, USA) were calculated using the Spearman correlation coefficient. A level of P < 0.05 
was chosen to indicate statistical significance. 
The Bland-and-Altman5 method was used to evaluate the agreement between the measurement 
taken with the standard and new methods, after assessing the normal distribution of the differences. 
The lack of agreement was summarized by calculating the bias, estimated by the mean difference 
(d) and the standard deviation of the differences (s). We expected that 95% of differences was 
between d-1.96s and d +1.96s.
Results
We obtained 120 coupled measurements for each method suitable for the V'CO2ML calculation and 
40 coupled measurements suitable for the VDsML calculation. Because of a failure of the 
capnometer’s heater system, the data recorded by one animal were judged potentially not reliable 
and not included.
As seen in Figures 2a-2b, we observed a strong correlation between the measurements of V'CO2ML, 
(rs=0.991; p=0.0005) taken with the volumetric capnometer, and those obtained with the standard 
method. Moreover, the volumetric capnometer showed a low mean percentage bias for V'CO2ML 
measurements at exactly 3.86% (12.07 – 4.35%).
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Regarding the dead space calculation, not only did we observed a significant strong correlation 
between the two methods for VDsML calculation (rs=0.973; p=0.0005), but we also identified a very 
low mean percentage bias with the volumetric capnometer at 2.62%( 8.96 – 14.20%), as it can be 
seen in Figures 3a-3b.
In addition, although a negative proportional bias for V'CO2ML estimation with the volumetric 
capnometer was observed, such underestimation in the lower range of V'CO2ML was less than 4%, 
which represents an acceptable limit for clinical setting.
Moreover, we investigated whether variations in gas temperature and gas flow/blood flow ratio could 
have affected the differences in the coupled measurements obtained with the two devices. In this 
regard, we found no significant correlations between the difference in the coupled V'CO2ML and 
VDsML measurements for either the gas flow/blood flow ratio or temperature.
Finally, Figure 4 shows the variation of VDsML at increasing gas flow/blood flow ratios. As it can be 
observed, increasing gas flow/blood flow ratios (increased ventilation per unit of blood) correspond 
to higher values of VDsML. This can be explained by the fact that the increase in the ventilation per 
unit of blood implies a corresponding increase in the ventilation per mm2 of oxygenator’s membrane 
up to a certain threshold, which is determined by the permeability properties of the membrane. Once 
the threshold has been reached, a further increase in ventilation will create an increase in dead 
space (in series).
Discussion
In the present study, we evaluated the accuracy and reliability of a new volumetric capnometer which 
allows the continuous V'CO2ML monitoring and VDsML calculation thanks to its two components. 
The flowmeter was placed in series to the sweep gas line, and the capnometer was positioned at 
the exhaust gas port of the oxygenator.
ECMO constitutes a life-saving mechanical support which often requires accurate monitoring and 
potentially prompt interventions because of either variation in patient clinical conditions, the 
occurrence of possible complications, or ECMO system malfunction. Thus, an appropriate and 
continuous monitoring of gas exchange inside the oxygenator is useful in order to evaluate both the 
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ML performance and to distinguish between the ML and native lungs (NL) ventilation2. Currently, 
data regarding ML gas exchange are usually obtained by taking blood samples by the ECMO circuit 
added to the volumetric capnometry of the ML during the routinely ECMO check at least daily. 
However, due to the complexity of the support machine, of the patient-machine interactions, together 
with the high risk of system-related complications during prolonged use, there could be a great 
benefit  by the use of an on-line monitoring system which can provide real-time information regarding 
both the ML and pump performances. In fact, the study of the trend in the V'CO2ML  permits to avoid 
bias related to the specific moment in wihich the single measurement has been taken, constituting 
a more realiable tool. Hence, we believe that the continuous monitoring of both CO2 removal and 
ML dead space with the volumetric capnometer allows a better timing for the detection of ML 
dysfunction and can potentally guide the ECMO weaning process by integrating ML and mechanical 
ventilator information. 
In addition, with regards to the patient complications related to ECMO use, it is reported that ML 
failure constitutes the second most common mechanical complication.6 Moreover, despite the advent 
of new ML coated with a tip-to-tip antithrombotic surface coating, the interactions of blood with non-
biological surfaces boost the systemic inflammatory response and lead to clotting within the ML7. 
Such deposits are responsible for the worsening of ML gas exchanges because of an increased 
dead space inside the oxygenator and, hence, of an increased proportion of ventilated but not 
perfused areas. Therefore, we believe that the continuous evaluation of the V'CO2ML other than the 
dead space not only can highlight an ML performance reduction, but also guide the ML replacement 
timing. For instance, providing that ML replacement does not constitute a no-risk procedure in those 
patients, the V'CO2ML evaluation could allow a monitored delay in its replacement , whenever the 
CO2 clearance is sufficient for the patient’s clinical needs.
In addition, discontinuing extracorporeal respiratory support is another crucial step in ECMO patient 
management, and it often constitutes a difficult decision, mainly due to the lack of definite criteria. 
Mols et al.8 indicated the successful weaning from the ECMO machine when at least 80% of total 
oxygen delivery was supplied by the patient’s own lung8. Similarly, Grasselli et al. 9 suggested that 
respiratory mechanics and patient blood gases should also be considered in the decision of ECMO 
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withdrawal. On the other hand, we previously reported how the combined evaluation of V'CO2ML 
and VCO2NL obtained by the volumetric capnometry function integrated in the modern ventilators 
could provide additional information regarding the  NL recovery such as improvements in its CO2 
clearance capability10. In our opinion, in fact, in order to estimate the residual function of the NL more 
accurately, clinicians should analyse not only the oxygenation function (V'O2ML) of the ML, but also 
the extracorporeal CO2 removal (V'CO2ML). Thus, the continuous V'CO2ML monitoring by the new 
volumetric capnometer could potentially help in analysing NL/ML interaction, guiding the ECMO 
weaning process and choosing the best timing for the ECMO discontinuation 3. 
Conclusions
In conclusion, our experimental study demonstrates that the volumetric capnometer used in 
conjunction with the ECMO oxygenator is reliable for continuous monitoring of V’CO2 and useful for 
oxygenator dead space calculation, as the measurements obtained with a standard method by a 
normal capnometer. Moreover, we believe that the information provided by such a device are helpful 
in order to promptly detect oxygenator malfunction and its impaired performance in terms of CO2 
removal. Furthermore, if these monitoring approach will be confirmed in future studies, the V’CO2ML 
continuous monitoring could help to better guide ECMO weaning and improve the the patient 
management. Further studies are vital in order to confirm our results in a clinical setting.
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List of abbreviations:
BF: blood flow
ECMO: extracorporeal membrane oxygenation
ML: membrane lung
NL: native lung
pCO2,out: CO2 blood partial pressure in the outlet blood from oxygenator
VA ECMO: veno-arterial extracorporeal membrane oxygenation 
VCO2NL: CO2 removal through the Native Lung
V'CO2ML: CO2 removal through the Membrane Lung
V'O2ML:  O2 transfer through the Membrane Lung
VDsML: Membrane Lung dead space
VV ECMO: veno-venous Extracorporeal Membrane Oxygenation
%CO2: concentration (%) of carbon dioxide in exhaust gas
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Legends to the Figures
Figure 1: the new volumetric capnometer is applied to the ECMO machine; at the top in the 
red circle the flowmeter, and at the bottom in the red circle the capnometer.
Figure 2: panel a. Correlation between the V'CO2ML values obtained with the volumetric 
capnometer with the values calculated with the standard method; panel b. Mean bias and precision 
of V'CO2ML values obtained with the volumetric capnometer compared to the values calculated with 
the standard method 
Figure 3: panel a. Correlation between the values of VDsML obtained by new volumetric 
capnometer versus the values calculated with the standard method ; panel b. Mean bias and 
precision of VDsML  values obtained with the volumetric capnometer compared to the values 
calculated with the standard method.
Figure 4: Scatter plot showing the values of the VDsML measured by the two methods at five 
different levels of BF/GF ratio. These data show that the increasing of gas BF/GF ratios 
corresponds to  an increase of the VDsML values, as consequence of the overcome capacity of 
the ML membrane in terms of CO2 elimination.
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